-+ 0.00%
-+ 0.00%
-+ 0.00%

Acumen Pharmaceuticals announces virtual investor day meeting

PUBT·09/10/2026 20:00:32
Listen to the news
Acumen Pharmaceuticals announces virtual investor day meeting
  • Acumen Pharmaceuticals will hold a virtual Investor Day meeting on September 16, 2026, in a virtual setting.
  • Management is set to present updates on the company’s Alzheimer’s disease pipeline, including sabirnetug (ACU193) and the ALTITUDE-AD Phase 2 program.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acumen Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609101600PRIMZONEFULLFEED9824298) on September 10, 2026, and is solely responsible for the information contained therein.